v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity and Income (unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Capital in Excess of Par
Retained Earnings
Accumulated Other Comprehensive Income
Non-controlling Interests
Beginning balance (in shares) at Dec. 31, 2022     127,173,000        
Beginning balance at Dec. 31, 2022 $ 1,356,564 $ 1,121,922 $ 127 $ 452,183 $ 581,010 $ 88,602 $ 234,642
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 70,805 70,805     70,805    
Net income attributable to non-controlling interests 12,811 0         12,811
Cash dividends declared for common stockholders ($0.125 per share) (15,897) (15,897)     (15,897)    
Issuance of restricted stock (in shares)     3,000        
Issuance of restricted stock 0 0 $ 0 0      
Vesting of restricted stock 10,003 10,003   10,003      
Issuance of non-controlling interests 2,731 0       2,731
Non-controlling interests acquired in business combination 3,877 0         3,877
Distributions to and purchases of non-controlling interests (6,069) 0         (6,069)
Redemption value adjustment on non-controlling interests (436) (436)     (436)    
Other comprehensive loss (15,948) (15,948)       (15,948)  
Other 0 0   (1) 1    
Ending balance (in shares) at Mar. 31, 2023     127,176,000        
Ending balance at Mar. 31, 2023 $ 1,418,441 1,170,449 $ 127 462,185 635,483 72,654 247,992
Beginning balance (in shares) at Dec. 31, 2023 128,369,492   128,369,000        
Beginning balance at Dec. 31, 2023 $ 1,547,718 1,288,304 $ 128 493,413 751,856 42,907 259,414
Increase (Decrease) in Stockholders' Equity              
Net income attributable to Select Medical Holdings Corporation 96,897 96,897     96,897    
Net income attributable to non-controlling interests 17,845 0         17,845
Cash dividends declared for common stockholders ($0.125 per share) (16,045) (16,045)     (16,045)    
Issuance of restricted stock (in shares)     1,000        
Issuance of restricted stock 0 0 $ 0 0      
Forfeitures of unvested restricted stock (in shares)     (12,000)        
Forfeitures of unvested restricted stock 14 14 $ 0 0 14    
Vesting of restricted stock 11,596 11,596   11,596      
Issuance of non-controlling interests 4,002 0         4,002
Distributions to and purchases of non-controlling interests (10,506) 394   394     (10,900)
Redemption value adjustment on non-controlling interests (1,901) (1,901)     (1,901)    
Other comprehensive loss $ (11,977) (11,977)       (11,977)  
Ending balance (in shares) at Mar. 31, 2024 128,357,832   128,358,000        
Ending balance at Mar. 31, 2024 $ 1,637,643 $ 1,367,282 $ 128 $ 505,403 $ 830,821 $ 30,930 $ 270,361